Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Local Ablative Therapy Followed by Osimertinib Rechallenge in Oligoprogressive, EGFR-Mutated NSCLC: A Phase 2 Study.
Journal: JTO clinical and research reports
Published: February 26, 2025
Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics.
Journal: Journal for immunotherapy of cancer
Published: August 08, 2023
Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung Cancer.
Journal: Cancer research communications
Published: July 28, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
Journal: Nature genetics
Published: June 25, 2023
Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance.
Journal: Cancers
Published: March 27, 2023
A Novel Recognition by the E3 Ubiquitin Ligase of HSV-1 ICP0 Enhances the Degradation of PML Isoform I to Prevent ND10 Reformation in Late Infection.
Journal: Viruses
Published: March 25, 2023
Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney.
Journal: The American journal of pathology
Published: March 09, 2023
Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities.
Journal: Cell reports. Medicine
Published: March 02, 2023
NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease.
Journal: The Journal of biological chemistry
Published: November 08, 2022
Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth.
Journal: The Journal of biological chemistry
Published: April 08, 2022
Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma.
Journal: Cancers
Published: September 13, 2021
Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells.
Journal: Cell reports
Published: August 17, 2021
Last Updated: 09/26/2026